Also known as: Mestinon; Regonol; 3-Hydroxy-1-methylpyridinium Bromide Dimethylcarbamate
Pyridostigmine Bromide is a reversible cholinesterase inhibitor used in the treatment of myasthenia gravis. Manufactured by Mediocon Inc at its GMP-certified facility in Aurangabad, Maharashtra, India, it is supplied in IP/BP/EP/USP grade for oral and parenteral pharmaceutical formulations worldwide. CAS No: 101-26-8.
| Parameter | Specification |
|---|---|
| CAS Number | 101-26-8 |
| Molecular Formula | C9H13BrN2O2 |
| Molecular Weight | 261.12 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Cholinesterase Inhibitor / Antimyasthenic Agent |
| Appearance | White to off-white hygroscopic crystalline powder |
| Solubility | Freely soluble in water and alcohol. |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Pyridostigmine Bromide — CAS 101-26-8 (CAS 101-26-8) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Pyridostigmine Bromide — CAS 101-26-8 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance